Safety and Efficacy of Golimumab Administered Intravenously in Adults with Ankylosing Spondylitis: Results through Week 28 of the GO-ALIVE Study.
Where this comes from
- Record sourced from PubMed, PMID 41922006.
- Also identified by DOI 10.3899/jrheum.170487.C2.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
J Rheumatol 2018; doi: 10.3899/jrheum.170487 Recently, the sponsor became aware of data errors related to Bath Ankylosing Spondylitis Metrology Index (BASMI) and the University of California San Francisco (UCSF) Enthesitis Index that occurred during the study. The ensuing tabular and in-text corrections are provided hereinafter.